Rachael Bartlett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rachael Bartlett has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Ronald Sluyter
Molecular Horizons and School of Science, University of Wollongong, Wollongong, Australia
4 shared publications - Justin J. Yerbury
Illawarra Health and Medical Research Institute, Wollongong, NSW, Australia
3 shared publications - Neil R. Cashman
Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, Canada
3 shared publications - Darren N. Saunders
School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
2 shared publications - Diane Ly
Illawarra Health and Medical Research Institute, Wollongong, Australia
2 shared publications - Fabien Delerue
Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
2 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by Springer Nature in Purinergic Signalling
- Vol. 22 (4) , 64
The P2X7 receptor: insights from the murine monoclonal antibody clone L4
The P2X7 receptor (or P2X7) is an ATP-gated ion channel with important roles in the immune and other body systems. Much has been garnered about P2X7 using the first published anti-human P2X7 monoclonal antibody (mAb) (clone L4). This mAb can be used to impair P2X7 channel and pore activity and events downstream of P2X7 activation in vitro and in vivo. Immunolabelling with this mAb has been used in flow and mass cytometry, confocal microscopy and immunohistochemistry to help establish the presence of P2X7 on human leukocytes and other primary cell types, as well as various malignant cell lines. This mAb has been applied to immunoprecipitate P2X7 to identify co-associated molecules to help uncover novel roles of the receptor such as phagocytosis. Recently, this mAb has been shown to mediate complement-dependent cytotoxicity, offering a new avenue of limiting P2X7-mediated processes by depleting P2X7 + cells. Finally, this mAb has been used to identify and characterise polymorphic and other variants of P2X7. This article will discuss the origins and various applications of the anti-P2X7 mAb (clone L4). As an early user of this mAb and pioneer of other purinergic technologies, this article is a tribute to the late Francesco Di Virgilio.
- 24 July 2026
- Published by Springer Nature in Purinergic Signalling
- Vol. 22 (4) , 64
Open AccessThe P2X7 receptor: insights from the murine monoclonal antibody clone L4
The P2X7 receptor (or P2X7) is an ATP-gated ion channel with important roles in the immune and other body systems. Much has been garnered about P2X7 using the first published anti-human P2X7 monoclonal antibody (mAb) (clone L4). This mAb can be used to impair P2X7 channel and pore activity and events downstream of P2X7 activation in vitro and in vivo. Immunolabelling with this mAb has been used in flow and mass cytometry, confocal microscopy and immunohistochemistry to help establish the presence of P2X7 on human leukocytes and other primary cell types, as well as various malignant cell lines. This mAb has been applied to immunoprecipitate P2X7 to identify co-associated molecules to help uncover novel roles of the receptor such as phagocytosis. Recently, this mAb has been shown to mediate complement-dependent cytotoxicity, offering a new avenue of limiting P2X7-mediated processes by depleting P2X7 + cells. Finally, this mAb has been used to identify and characterise polymorphic and other variants of P2X7. This article will discuss the origins and various applications of the anti-P2X7 mAb (clone L4). As an early user of this mAb and pioneer of other purinergic technologies, this article is a tribute to the late Francesco Di Virgilio.
- Open Access
- 10 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Development of a targeted BioPROTAC degrader selective for misfolded SOD1
The accumulation of misfolded proteins underlies a broad range of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Due to their dynamic nature, these misfolded proteins have proven challenging to target therapeutically. Here, we specifically target misfolded disease variants of the ALS-associated protein superoxide dismutase 1 (SOD1), using a biological proteolysis targeting chimera (BioPROTAC) composed of a SOD1-specific intrabody and an E3 ubiquitin ligase. Screening of intrabodies and E3 ligases for optimal BioPROTAC construction reveals a candidate capable of degrading multiple disease variants of SOD1, preventing their aggregation in cells. Using CRISPR/Cas9 technology to develop a BioPROTAC transgenic mouse line, we demonstrate that the presence of the BioPROTAC delays disease progression in the SOD1 G93A mouse model of ALS. Delayed disease progression is associated with protection of motor neurons, a reduction of insoluble SOD1 accumulation and preservation of innervated neuromuscular junctions. These findings provide proof-of-concept evidence and a platform for developing BioPROTACs as a therapeutic strategy for the targeted degradation of neurotoxic misfolded species in the context of neurodegenerative diseases.
- 10 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessDevelopment of a targeted BioPROTAC degrader selective for misfolded SOD1
The accumulation of misfolded proteins underlies a broad range of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Due to their dynamic nature, these misfolded proteins have proven challenging to target therapeutically. Here, we specifically target misfolded disease variants of the ALS-associated protein superoxide dismutase 1 (SOD1), using a biological proteolysis targeting chimera (BioPROTAC) composed of a SOD1-specific intrabody and an E3 ubiquitin ligase. Screening of intrabodies and E3 ligases for optimal BioPROTAC construction reveals a candidate capable of degrading multiple disease variants of SOD1, preventing their aggregation in cells. Using CRISPR/Cas9 technology to develop a BioPROTAC transgenic mouse line, we demonstrate that the presence of the BioPROTAC delays disease progression in the SOD1 G93A mouse model of ALS. Delayed disease progression is associated with protection of motor neurons, a reduction of insoluble SOD1 accumulation and preservation of innervated neuromuscular junctions. These findings provide proof-of-concept evidence and a platform for developing BioPROTACs as a therapeutic strategy for the targeted degradation of neurotoxic misfolded species in the context of neurodegenerative diseases.
- Open Access
- 10 March 2025
- Published by Springer Nature in Research Square
Development of a targeted BioPROTAC degrader selective for misfolded SOD1
The accumulation of misfolded protein species underlies a broad range of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Due to their dynamic nature, these misfolded proteins have proven challenging to target therapeutically. Here, we specifically target misfolded disease variants of the ALS-associated protein; SOD1, using a biological proteolysis targeting chimera (BioPROTAC) composed of a SOD1-specific intrabody and an E3 ubiquitin ligase. Screening of intrabodies and E3 ligases for optimal BioPROTAC construction revealed a candidate capable of degrading multiple disease variants of SOD1, preventing their aggregation in cultured cells. Using CRISPR/Cas9 technology to develop a BioPROTAC transgenic mouse line, we demonstrate that the presence of the BioPROTAC delays disease progression in the SOD1G93A mouse model of ALS. Delayed disease progression was associated with protection of motor neurons, reduced accumulation of insoluble SOD1 and protection of neuromuscular junctions. These findings provide proof-of-concept evidence and a platform for developing BioPROTACs as a therapeutic strategy for the targeted degradation of neurotoxic misfolded species in the context of neurodegenerative diseases.
- 10 March 2025
- Published by Springer Nature in Research Square
Open AccessDevelopment of a targeted BioPROTAC degrader selective for misfolded SOD1
The accumulation of misfolded protein species underlies a broad range of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Due to their dynamic nature, these misfolded proteins have proven challenging to target therapeutically. Here, we specifically target misfolded disease variants of the ALS-associated protein; SOD1, using a biological proteolysis targeting chimera (BioPROTAC) composed of a SOD1-specific intrabody and an E3 ubiquitin ligase. Screening of intrabodies and E3 ligases for optimal BioPROTAC construction revealed a candidate capable of degrading multiple disease variants of SOD1, preventing their aggregation in cultured cells. Using CRISPR/Cas9 technology to develop a BioPROTAC transgenic mouse line, we demonstrate that the presence of the BioPROTAC delays disease progression in the SOD1G93A mouse model of ALS. Delayed disease progression was associated with protection of motor neurons, reduced accumulation of insoluble SOD1 and protection of neuromuscular junctions. These findings provide proof-of-concept evidence and a platform for developing BioPROTACs as a therapeutic strategy for the targeted degradation of neurotoxic misfolded species in the context of neurodegenerative diseases.
- Open Access
- 28 April 2022
- Published by Springer Nature in Purinergic Signalling
- Vol. 18 (4) , 451-467
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
Mutant superoxide dismutase 1 (SOD1) can be constitutively released from motor neurons and transmitted to naïve motor neurons to promote the progression of amyotrophic lateral sclerosis (ALS). However, the biological impacts of this process and the precise mechanisms of SOD1 release remain to be fully resolved. Using biochemical and fluorescent techniques, this study aimed to determine if P2X7 receptor activation could induce mutant SOD1 release from motor neurons and whether this released SOD1 could be transmitted to motor neurons or microglia to mediate effects associated with neurodegeneration in ALS. Aggregated SOD1G93A, released from murine NSC-34 motor neurons transiently transfected with SOD1G93A, could be transmitted to naïve NSC-34 cells and murine EOC13 microglia to induce endoplasmic reticulum (ER) stress and tumour necrosis factor-alpha (TNFα) release, respectively. Immunoblotting revealed NSC-34 cells expressed P2X7. Extracellular ATP induced cation dye uptake into these cells, which was blocked by the P2X7 antagonist AZ10606120, demonstrating these cells express functional P2X7. Moreover, ATP induced the rapid release of aggregated SOD1G93A from NSC-34 cells transiently transfected with SOD1G93A, a process blocked by AZ10606120 and revealing a role for P2X7 in this process. ATP-induced SOD1G93A release coincided with membrane blebbing. Finally, aggregated SOD1G93A released via P2X7 activation could also be transmitted to NSC-34 and EOC13 cells to induce ER stress and TNFα release, respectively. Collectively, these results identify a novel role for P2X7 in the prion-like propagation of SOD1 in ALS and provide a possible explanation for the therapeutic benefits of P2X7 antagonism previously observed in ALS SOD1G93A mice.
- 28 April 2022
- Published by Springer Nature in Purinergic Signalling
- Vol. 18 (4) , 451-467
Open AccessP2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
Mutant superoxide dismutase 1 (SOD1) can be constitutively released from motor neurons and transmitted to naïve motor neurons to promote the progression of amyotrophic lateral sclerosis (ALS). However, the biological impacts of this process and the precise mechanisms of SOD1 release remain to be fully resolved. Using biochemical and fluorescent techniques, this study aimed to determine if P2X7 receptor activation could induce mutant SOD1 release from motor neurons and whether this released SOD1 could be transmitted to motor neurons or microglia to mediate effects associated with neurodegeneration in ALS. Aggregated SOD1G93A, released from murine NSC-34 motor neurons transiently transfected with SOD1G93A, could be transmitted to naïve NSC-34 cells and murine EOC13 microglia to induce endoplasmic reticulum (ER) stress and tumour necrosis factor-alpha (TNFα) release, respectively. Immunoblotting revealed NSC-34 cells expressed P2X7. Extracellular ATP induced cation dye uptake into these cells, which was blocked by the P2X7 antagonist AZ10606120, demonstrating these cells express functional P2X7. Moreover, ATP induced the rapid release of aggregated SOD1G93A from NSC-34 cells transiently transfected with SOD1G93A, a process blocked by AZ10606120 and revealing a role for P2X7 in this process. ATP-induced SOD1G93A release coincided with membrane blebbing. Finally, aggregated SOD1G93A released via P2X7 activation could also be transmitted to NSC-34 and EOC13 cells to induce ER stress and TNFα release, respectively. Collectively, these results identify a novel role for P2X7 in the prion-like propagation of SOD1 in ALS and provide a possible explanation for the therapeutic benefits of P2X7 antagonism previously observed in ALS SOD1G93A mice.
- Top Cited PapersOpen Access
- 21 January 2020
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 18 (1) , e3000595
A role for triglyceride lipase brummer in the regulation of sex differences in Drosophila fat storage and breakdown
Triglycerides are the major form of stored fat in all animals. One important determinant of whole-body fat storage is whether an animal is male or female. Here, we useDrosophila, an established model for studies on triglyceride metabolism, to gain insight into the genes and physiological mechanisms that contribute to sex differences in fat storage. Our analysis of triglyceride storage and breakdown in both sexes identified a role for triglyceride lipasebrummer(bmm) in the regulation of sex differences in triglyceride homeostasis. Normally, male flies have higher levels ofbmmmRNA both under normal culture conditions and in response to starvation, a lipolytic stimulus. We find that loss ofbmmlargely eliminates the sex difference in triglyceride storage and abolishes the sex difference in triglyceride breakdown via strongly male-biased effects. Although we show thatbmmfunction in the fat body affects whole-body triglyceride levels in both sexes, in males, we identify an additional role forbmmfunction in the somatic cells of the gonad and in neurons in the regulation of whole-body triglyceride homeostasis. Furthermore, we demonstrate that lipid droplets are normally present in both the somatic cells of the male gonad and in neurons, revealing a previously unrecognized role forbmmfunction, and possibly lipid droplets, in these cell types in the regulation of whole-body triglyceride homeostasis. Taken together, our data reveal a role forbmmfunction in the somatic cells of the gonad and in neurons in the regulation of male–female differences in fat storage and breakdown and identifybmmas a link between the regulation of triglyceride homeostasis and biological sex.
- 21 January 2020
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 18 (1) , e3000595
Top Cited PapersOpen AccessA role for triglyceride lipase brummer in the regulation of sex differences in Drosophila fat storage and breakdown
Triglycerides are the major form of stored fat in all animals. One important determinant of whole-body fat storage is whether an animal is male or female. Here, we useDrosophila, an established model for studies on triglyceride metabolism, to gain insight into the genes and physiological mechanisms that contribute to sex differences in fat storage. Our analysis of triglyceride storage and breakdown in both sexes identified a role for triglyceride lipasebrummer(bmm) in the regulation of sex differences in triglyceride homeostasis. Normally, male flies have higher levels ofbmmmRNA both under normal culture conditions and in response to starvation, a lipolytic stimulus. We find that loss ofbmmlargely eliminates the sex difference in triglyceride storage and abolishes the sex difference in triglyceride breakdown via strongly male-biased effects. Although we show thatbmmfunction in the fat body affects whole-body triglyceride levels in both sexes, in males, we identify an additional role forbmmfunction in the somatic cells of the gonad and in neurons in the regulation of whole-body triglyceride homeostasis. Furthermore, we demonstrate that lipid droplets are normally present in both the somatic cells of the male gonad and in neurons, revealing a previously unrecognized role forbmmfunction, and possibly lipid droplets, in these cell types in the regulation of whole-body triglyceride homeostasis. Taken together, our data reveal a role forbmmfunction in the somatic cells of the gonad and in neurons in the regulation of male–female differences in fat storage and breakdown and identifybmmas a link between the regulation of triglyceride homeostasis and biological sex.
- Open Access
- 1 January 2017
- Published by Medknow in Neural Regeneration Research
- Vol. 12 (5) , 749-+
P2X7 receptor antagonism in amyotrophic lateral sclerosis
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,China
- 1 January 2017
- Published by Medknow in Neural Regeneration Research
- Vol. 12 (5) , 749-+
Open AccessP2X7 receptor antagonism in amyotrophic lateral sclerosis
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,China
- Open Access
- 1 January 2013
- Published by Wiley in Mediators of Inflammation
- Vol. 2013, 1-18
P2X7 Receptor Activation Induces Reactive Oxygen Species Formation and Cell Death in Murine EOC13 Microglia
The P2X7 purinergic receptor is a ligand-gated cation channel expressed on leukocytes including microglia. This study aimed to determine if P2X7 activation induces the uptake of organic cations, reactive oxygen species (ROS) formation, and death in the murine microglial EOC13 cell line. Using the murine macrophage J774 cell line as a positive control, RT-PCR, immunoblotting, and immunolabelling established the presence of P2X7 in EOC13 cells. A cytofluorometric assay demonstrated that the P2X7 agonists adenosine-5′-triphosphate (ATP) and 2′(3′)-O-(4-benzoylbenzoyl) ATP induced ethidium+or YO-PRO-12+uptake into both cell lines. ATP induced ethidium+uptake into EOC13 cells in a concentration-dependent manner, with an EC50of~130 μM. The P2X7 antagonists Brilliant Blue G, A438079, AZ10606120, and AZ11645373 inhibited ATP-induced cation uptake into EOC13 cells by 75–100%. A cytofluorometric assay demonstrated that P2X7 activation induced ROS formation in EOC13 cells, via a mechanism independent of Ca2+influx and K+efflux. Cytofluorometric measurements of Annexin-V binding and 7AAD uptake demonstrated that P2X7 activation induced EOC13 cell death. The ROS scavenger N-acetyl-L-cysteine impaired both P2X7-induced EOC13 ROS formation and cell death, suggesting that ROS mediate P2X7-induced EOC13 death. In conclusion, P2X7 activation induces the uptake of organic cations, ROS formation, and death in EOC13 microglia.
- 1 January 2013
- Published by Wiley in Mediators of Inflammation
- Vol. 2013, 1-18
Open AccessP2X7 Receptor Activation Induces Reactive Oxygen Species Formation and Cell Death in Murine EOC13 Microglia
The P2X7 purinergic receptor is a ligand-gated cation channel expressed on leukocytes including microglia. This study aimed to determine if P2X7 activation induces the uptake of organic cations, reactive oxygen species (ROS) formation, and death in the murine microglial EOC13 cell line. Using the murine macrophage J774 cell line as a positive control, RT-PCR, immunoblotting, and immunolabelling established the presence of P2X7 in EOC13 cells. A cytofluorometric assay demonstrated that the P2X7 agonists adenosine-5′-triphosphate (ATP) and 2′(3′)-O-(4-benzoylbenzoyl) ATP induced ethidium+or YO-PRO-12+uptake into both cell lines. ATP induced ethidium+uptake into EOC13 cells in a concentration-dependent manner, with an EC50of~130 μM. The P2X7 antagonists Brilliant Blue G, A438079, AZ10606120, and AZ11645373 inhibited ATP-induced cation uptake into EOC13 cells by 75–100%. A cytofluorometric assay demonstrated that P2X7 activation induced ROS formation in EOC13 cells, via a mechanism independent of Ca2+influx and K+efflux. Cytofluorometric measurements of Annexin-V binding and 7AAD uptake demonstrated that P2X7 activation induced EOC13 cell death. The ROS scavenger N-acetyl-L-cysteine impaired both P2X7-induced EOC13 ROS formation and cell death, suggesting that ROS mediate P2X7-induced EOC13 death. In conclusion, P2X7 activation induces the uptake of organic cations, ROS formation, and death in EOC13 microglia.
- 1 October 1993
- Published by Wiley in New Zealand Journal of Botany
- Vol. 31 (4) , 361-373
Patterns of species composition, recruitment, and growth within canopy gaps in two New Zealand kauri ( Agathis australis ) forests
Within‐gap patterns of forest species composition, tree growth, and associated micro‐climate were investigated in two kauri ( Agathis australis ) forests in northern New Zealand. Detrended correspondence analysis (DCA) of sites at Trounson Kauri Park revealed a gradient of changing species composition from gap centre to forest understorey. However, while some species were typical either of the understorey (e.g., Dysoxlylum spectabile ) or the centre of large gaps (e.g., Knightia excelsa, Leucopogon fasciculata ), no species was restricted solely to gap edge sites. Growth of potted tree seedlings over 6 months at different locations in and near a large canopy gap revealed a significant positive relationship between percent canopy openness (%CO) and height increase for each of the five species tested. The early successional tree Kunzea ericoides showed the greatest height increase at gap centre, while the long‐lived conifer Dacrydium cupressinum had the greatest height increase in the forest understorey. DCA of within‐gap vegetation at Huapai Reserve over the first 5 years following gap formation revealed several trends: (1) sample plots in the root zone on the southern side of the gap were most similar to gap centre plots, while those on the northern side were most similar to the forest understorey; (2) species composition (DCA loadings on the first axis) was significantly correlated with %CO; (3) at 9 of 10 sample locations within the gap, resprouts and individuals from the seedling bank were more likely to capture the available canopy space than seedlings established after gap creation.
- 1 October 1993
- Published by Wiley in New Zealand Journal of Botany
- Vol. 31 (4) , 361-373
Patterns of species composition, recruitment, and growth within canopy gaps in two New Zealand kauri ( Agathis australis ) forests
Within‐gap patterns of forest species composition, tree growth, and associated micro‐climate were investigated in two kauri ( Agathis australis ) forests in northern New Zealand. Detrended correspondence analysis (DCA) of sites at Trounson Kauri Park revealed a gradient of changing species composition from gap centre to forest understorey. However, while some species were typical either of the understorey (e.g., Dysoxlylum spectabile ) or the centre of large gaps (e.g., Knightia excelsa, Leucopogon fasciculata ), no species was restricted solely to gap edge sites. Growth of potted tree seedlings over 6 months at different locations in and near a large canopy gap revealed a significant positive relationship between percent canopy openness (%CO) and height increase for each of the five species tested. The early successional tree Kunzea ericoides showed the greatest height increase at gap centre, while the long‐lived conifer Dacrydium cupressinum had the greatest height increase in the forest understorey. DCA of within‐gap vegetation at Huapai Reserve over the first 5 years following gap formation revealed several trends: (1) sample plots in the root zone on the southern side of the gap were most similar to gap centre plots, while those on the northern side were most similar to the forest understorey; (2) species composition (DCA loadings on the first axis) was significantly correlated with %CO; (3) at 9 of 10 sample locations within the gap, resprouts and individuals from the seedling bank were more likely to capture the available canopy space than seedlings established after gap creation.
- 1 March 1991
- Published by JSTOR in Journal of Ecology
- Vol. 79 (1) , 183
Multiple Controls of Cliff-Edge Distribution Patterns of Thuja Occidentalis and Acer Saccharum at The Stage of Seedling Recruitment
- 1 March 1991
- Published by JSTOR in Journal of Ecology
- Vol. 79 (1) , 183
Multiple Controls of Cliff-Edge Distribution Patterns of Thuja Occidentalis and Acer Saccharum at The Stage of Seedling Recruitment